Lifted Regulatory Overhang Raises Cadila’s Value
Executive Summary
Cadila Healthcare, the listed flagship of billionaire Pankaj Patel’s Zydus Group, has become India’s second most valuable pharmaceutical firm after its shares were lifted by the resolution of US regulatory issues engulfing its biggest manufacturing plant, and a string of drug approvals.